Aleafia Health Inc.
ALEAF · OTC
3/31/2023 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $43 | $45 | $16 | $3 |
| % Growth | -3.8% | 172.4% | 391% | – |
| Cost of Goods Sold | $37 | $50 | -$4 | $1 |
| Gross Profit | $6 | -$6 | $21 | $3 |
| % Margin | 14% | -12.6% | 127.1% | 83.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $18 | $32 | $39 | $20 |
| SG&A Expenses | $20 | $32 | $39 | $21 |
| Sales & Mktg Exp. | $2 | $0 | $0 | $1 |
| Other Operating Expenses | $3 | $8 | $6 | $2 |
| Operating Expenses | $24 | $40 | $45 | $23 |
| Operating Income | -$18 | $154 | -$24 | -$20 |
| % Margin | -40.9% | 345.2% | -146.7% | -594.9% |
| Other Income/Exp. Net | -$17 | -$404 | -$13 | $0 |
| Pre-Tax Income | -$35 | -$250 | -$37 | -$20 |
| Tax Expense | $8 | -$3 | $3 | -$1 |
| Net Income | -$42 | -$247 | -$40 | -$19 |
| % Margin | -98.8% | -555.1% | -242.2% | -556.5% |
| EPS | -0.11 | -0.85 | -0.18 | -0.16 |
| % Growth | 87.1% | -372.2% | -12.5% | – |
| EPS Diluted | -0.11 | -0.85 | -0.18 | -0.16 |
| Weighted Avg Shares Out | 386 | 292 | 216 | 117 |
| Weighted Avg Shares Out Dil | 386 | 292 | 216 | 117 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9 | $404 | $6 | $0 |
| Depreciation & Amortization | $7 | $10 | $7 | $2 |
| EBITDA | -$11 | $164 | -$17 | -$18 |
| % Margin | -25.6% | 368% | -106.1% | -548.1% |